-
Brexpiprazole, sold
under the
brand name
Rexulti among others, is an
atypical antipsychotic medication used for the
treatment of
major depressive disorder...
- vilazodone. It is
similar to the
marketing strategy used for the drug
brexpiprazole,
labeling it as a "serotonin-dopamine
activity modulator" or 'SDAM'...
-
efficacy as
adjunctive agents; and, such
agents include:
Aripiprazole Brexpiprazole Cariprazine Olanzapine Quetiapine Ziprasidone whereas only quetiapine...
- (Abilify) –
approved as an
adjunct to
antidepressant for
major depression Brexpiprazole (Rexulti) –
approved as an
adjunct to
antidepressant for
major depression...
- focus.11.3.352. O'Connor,
Manjula (2020). "Adjunctive
therapy with
brexpiprazole improves treatment resistant complex post
traumatic stress disorder...
-
Modafinil - The (R)-(−)-enantiomer,
known as
Armodafinil in its pure form
Brexpiprazole Cariprazine Cannabidiol GSK-789,472 – Also D3 antagonist, with good...
-
triggered by the
onset of agitation). On May 11, 2023, the FDA
approved brexpiprazole (brand name – Rexulti) as a
prescription medication for
treatment of...
-
dopamine and
serotonin receptors. The drug is also
related structurally to
brexpiprazole and cariprazine. In
October 2023,
Reviva Pharmaceuticals released topline...
- control/addictive
behaviors such as
habitual self-mutilation
Rexulti (
brexpiprazole) –
atypical antipsychotic used to
treat mood and
psychotic disorders...
- antidepressant)
Aripiprazole (atypical antipsychotic,
trade name: Abilify)
Brexpiprazole (atypical antipsychotic,
trade name: Rexulti)
Azelastine Bilastine...
